. Dr, Schürks is a full-time employee of Bayer HealthCare Germany

. Dr-allergan, . Almirall, A. Amgen, . Technology, B. Astrazeneca et al., Financial support for research projects was provided by Allergan, Diener received honoraria for participation in clinical trials and Pfizer. Headache research at the Department of Neurology in Essen is supported by the German Research Council (DFG), the German Ministry of Education and Research (BMBF) and the European Union. Dr. Diener has no ownership interest and does not own stocks of any pharmaceutical company

. Dr, Kurth has received investigator-initiated research funding from the French National Research Agency and the US National Institutes of Health. Further, he has received honoraria from the BMJ and Cephalalgia for editorial services

. Dr, Grabe is receiving funds from the German Research Foundation and the Federal Ministry of Education and Research in Germany. During the last three years he has received speaker's honoraria from SERVIER and Eli Lilly Author details 1

F. Bordeaux, College of Health Sciences, F-33000, 18435.

A. May, A. Bahra, C. Buchel, R. Frackowiak, and P. Goadsby, Hypothalamic activation in cluster headache attacks, The Lancet, vol.352, issue.9124, pp.275-278, 1998.
DOI : 10.1016/S0140-6736(98)02470-2

G. Francis, W. Becker, and T. Pringsheim, Acute and preventive pharmacologic treatment of cluster headache, Neurology, vol.75, issue.5, pp.463-473, 2010.
DOI : 10.1212/WNL.0b013e3181eb58c8

S. Law, S. Derry, and R. Moore, Triptans for acute cluster headache, Cochrane Database Syst Rev, vol.7, p.8042, 2013.

A. May, M. Leone, J. Afra, M. Linde, P. Sandor et al., EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias, European Journal of Neurology, vol.58, issue.10, pp.1066-1077, 2006.
DOI : 10.1046/j.1468-2982.2003.00551.x

M. Schürks, T. Kurth, J. De-jesus, M. Jonjic, D. Rosskopf et al., Cluster Headache: Clinical Presentation, Lifestyle Features, and Medical Treatment, Headache: The Journal of Head and Face Pain, vol.64, issue.8, pp.1246-1254, 2006.
DOI : 10.1046/j.1468-2982.2003.00585.x

A. Serretti, R. Calati, L. Mandelli, D. Ronchi, and D. , Serotonin Transporter Gene Variants and Behavior: A Comprehensive Review, Current Drug Targets, vol.7, issue.12, pp.1659-1669, 2006.
DOI : 10.2174/138945006779025419

K. Lesch, D. Bengel, A. Heils, S. Sabol, B. Greenberg et al., Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region, Science, vol.274, issue.5292, pp.1527-1531, 1996.
DOI : 10.1126/science.274.5292.1527

J. Wendland, B. Martin, M. Kruse, K. Lesch, and D. Murphy, Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531, Molecular Psychiatry, vol.29, issue.3, pp.224-2264001789, 2006.
DOI : 10.1038/sj.mp.4001789

X. Hu, R. Lipsky, G. Zhu, L. Akhtar, J. Taubman et al., Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive-Compulsive Disorder, The American Journal of Human Genetics, vol.78, issue.5, pp.815-826, 1086.
DOI : 10.1086/503850

G. Zalsman, Y. Huang, M. Oquendo, A. Burke, X. Hu et al., Association of a Triallelic Serotonin Transporter Gene Promoter Region (5-HTTLPR) Polymorphism With Stressful Life Events and Severity of Depression, American Journal of Psychiatry, vol.163, issue.9, pp.1588-1593, 2006.
DOI : 10.1176/ajp.2006.163.9.1588

H. Grabe, C. Schwahn, J. Mahler, A. Schulz, C. Spitzer et al., Moderation of adult depression by the serotonin transporter promoter variant (5-HTTLPR), childhood abuse and adult traumatic events in a general population sample, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol.66, issue.11, pp.298-309, 2012.
DOI : 10.1002/ajmg.b.32027

M. Thompson, N. Gonzalez, T. Nguyen, D. Comings, S. George et al., Serotonin transporter gene polymorphisms in alcohol dependence, Alcohol, vol.22, issue.2, pp.61-67, 2000.
DOI : 10.1016/S0741-8329(00)00105-1

D. Albani, A. Vittori, S. Batelli, L. Polito, D. Mauro et al., Serotonin Transporter Gene Polymorphic Element <i>5-HTTLPR</i> Increases the Risk of Sporadic Parkinson&rsquo;s Disease in Italy, European Neurology, vol.62, issue.2, pp.120-12310, 2009.
DOI : 10.1159/000222784

M. Robbins, The Psychiatric Comorbidities of Cluster Headache, Current Pain and Headache Reports, vol.51, issue.Suppl 1, p.313, 2013.
DOI : 10.1007/s11916-012-0313-8

A. Dombrovski, B. Mulsant, R. Ferrell, F. Lotrich, J. Rosen et al., Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms, International Clinical Psychopharmacology, vol.25, issue.1, pp.37-4510, 2010.
DOI : 10.1097/YIC.0b013e328333ee10

E. Kosek, K. Jensen, T. Lonsdorf, M. Schalling, and M. Ingvar, Genetic Variation in the Serotonin Transporter Gene (5-HTTLPR, Rs25531) Influences the Analgesic Response to the Short Acting Opioid Remifentanil in Humans, Molecular Pain, vol.295, issue.18, 2009.
DOI : 10.1126/science.274.5292.1527

A. Bahra, M. Gawel, J. Hardebo, D. Millson, S. Breen et al., Oral zolmitriptan is effective in the acute treatment of cluster headache, Neurology, vol.54, issue.9, pp.1832-1839, 2000.
DOI : 10.1212/WNL.54.9.1832

J. Van-vliet, A. Bahra, V. Martin, N. Ramadan, S. Aurora et al., Intranasal sumatriptan in cluster headache: Randomized placebo-controlled double-blind study, Neurology, vol.60, issue.4, pp.630-633, 2003.
DOI : 10.1212/01.WNL.0000046589.45855.30

T. Bird, G. Jarvik, and N. Wood, Genetic association studies: Genes in search of diseases, Neurology, vol.57, issue.7, pp.1153-1154, 2001.
DOI : 10.1212/WNL.57.7.1153

M. Schürks, T. Kurth, I. Geissler, G. Tessmann, H. Diener et al., The G1246A polymorphism in the hypocretin receptor 2 gene is not associated with treatment response in cluster headache, Cephalalgia, vol.57, issue.4, pp.363-367, 2007.
DOI : 10.1124/jpet.105.090951

M. Schürks, T. Kurth, I. Geissler, G. Tessmann, H. Diener et al., Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene, Neurology, vol.66, issue.12, pp.1917-1919, 2006.
DOI : 10.1212/01.wnl.0000215852.35329.34

I. Rainero, S. Gallone, W. Valfre, M. Ferrero, G. Angilella et al., A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache, Neurology, vol.63, issue.7, pp.1286-1288, 2004.
DOI : 10.1212/01.WNL.0000142424.65251.DB

M. Thompson, H. Xhaard, T. Sakurai, I. Rainero, and J. Kukkonen, OX1 and OX2 orexin/hypocretin receptor pharmacogenetics, Frontiers in Neuroscience, vol.485, issue.8, 2014.
DOI : 10.1002/cne.20515

M. Schürks, T. Kurth, P. Stude, C. Rimmbach, J. De-jesus et al., G Protein ??3 Polymorphism and Triptan Response in Cluster Headache, Clinical Pharmacology & Therapeutics, vol.46, issue.4, pp.396-401, 2007.
DOI : 10.1038/sj.clpt.6100159

S. Lin, S. Setya, N. Johnson-farley, and D. Cowen, family, British Journal of Pharmacology, vol.151, issue.7, pp.1072-1078, 2002.
DOI : 10.1038/sj.bjp.0704809

URL : https://hal.archives-ouvertes.fr/hal-00275274

M. Thompson, S. Noble-topham, M. Percy, D. Andrade, and G. Ebers, Chromosome 1p36 in migraine with aura, NeuroReport, vol.23, issue.1, pp.45-48, 2012.
DOI : 10.1097/WNR.0b013e32834e5af3

M. Schürks, P. Rist, and T. Kurth, 5-HTTLPR polymorphism in the serotonin transporter gene and migraine: A systematic review and meta-analysis, Cephalalgia, vol.118, issue.1, pp.1296-130510, 2010.
DOI : 10.1111/j.1468-2982.2007.01500.x

S. Terrazzino, C. Tassorelli, G. Sances, A. M. Viana, M. Monaco et al., Association of haplotype combination of serotonin transporter gene polymorphisms with monthly headache days in MOH patients, European Journal of Neurology, vol.50, issue.1, pp.69-751129, 2012.
DOI : 10.1111/j.1468-1331.2011.03436.x